Model Information:

Metastatic adenocarcinoma in LN, consider originate from pancreas. IHC results: CK(++), CK7(++), CK18(+), CK19(++), CK20(-), CK34(++), CEA(+), CA125(+), CA19-9(+), Ki67(++), AFP(-), Hepatocyte(+/-), Syn(-), Vimentin(-), LCA(+).

Summary

Cancer Type Pancreatic Cancer
Subtype ADC
Grade NA
Stage NA
Ethnicity Asian
Gender F
Age NA
Pathology Diagnosis

Metastatic adenocarcinoma in LN, consider originate from pancreas. IHC results: CK(++), CK7(++), CK18(+), CK19(++), CK20(-), CK34(++), CEA(+), CA125(+), CA19-9(+), Ki67(++), AFP(-), Hepatocyte(+/-), Syn(-), Vimentin(-), LCA(+).

Biopsy Site metastatic, LN
Treatment History NA
Pathology QC Poorly differentiated adenocarcinoma (Pa, P3). (IHC (P3, P7): TTF1(-), CDX2(+/-),CK7(3+), CK20(3+), CA199(+/-).)
Special Features NA
Mouse Strain Balb/c nu
TMA TMA-HP-PA-018
Viral Status in PDX NA
Available In CB_CN
RNA Seq P3
Exome Seq P4

Growth Characteristics

Additional Characteristics